首页|复方中草药四味穿心莲益生菌发酵产物对鸡大肠杆菌作用

复方中草药四味穿心莲益生菌发酵产物对鸡大肠杆菌作用

扫码查看
为探究复方中草药四味穿心莲益生菌发酵产物(FPSCS)对鸡大肠杆菌的作用,采用微孔-平板法测定其对O2型鸡大肠杆菌的最小抑菌浓度(MIC)和最小杀菌浓度(MBC),以O2型鸡大肠杆菌半数致死量(LD50)感染SPF雏鸡制备病理模型,随机分为FPSCS高、中、低剂量组,硫酸新霉素组,四味穿心莲散组,益生菌组及对照组,统计总有效率、治愈率;ELISA试剂盒检测各组动物外周血液中炎症因子的含量.结果显示:FPSCS体外对O2型鸡大肠杆菌的MIC和MBC均为31.25 mg/mL,口服FPSCS剂量为0.1~0.5 g/(次·只)的总有效率为73.33%~83.33%、治愈率为70%~80%,均显著高于四味穿心莲散组和益生菌组(P<0.05),且治疗初期可显著降低促炎因子TNF-α、IL-1β、IL-6的含量(P<0.05),显著升高IFN-γ的含量(P<0.05).由此表明,FPSCS可通过抑杀O2型鸡大肠杆菌和降低鸡外周血促炎因子的含量而发挥较好的抗菌活性.
Effect of probiotics fermentation products of compound traditional Chinese medicine Siwei Chuanxinlian on chicken Escherichia coli
In order to investigate the effect of probiotic fermentation products(FPSCS)of compound traditional Chinese medicine Siwei Chuanxinlian(FPSCS)on chicken Escherichia coli(E.coli),the minimum inhibitory concentration(MIC)and minimum bactericidal concentration(MBC)of FPSCS against type O2 E.coli were determined by microporous plate method,and the specific pathogen free(SPF)chicken were infected with half lethal dose(LD50)of type O2 E.coli to prepare pathological model.They were randomly divided into high-dose group,medium-dose group and low-dose group of FPSCS,neomycin sulfate group,Siwei Chuanxinlian San group,probiotics group and control group.The total effective rate and cure rate of each group were analyzed,and the contents of inflammatory factors in peripheral blood of tested animals were detected by enzyme linked immunosorbent assay(ELISA)kits.The results showed that the MIC and MBC of FPSCS against Escherichia coli type O2 were 31.25 mg/mL in vitro,and the total effective rate of 0.1~0.5 g/(time·only)of FPSCS was 73.33%~83.33% and the cure rate was 70%~80%,which were significantly higher than those of Siwei Chuanxinlian San group and probiotics group(P<0.05).At the beginning of treatment,the contents of TNF-ct,IL-1β and IL-6 were significantly decreased(P<0.05),and the contents of IFN-γ were significantly increased(P<0.05).These conclusion indicated that FPSCS could exert good antibacterial activity by inhibiting type O2 E.coli and reducing the content of proinflammatory factor in chicken.

Siwei Chuanxinlian Sanprobioticsfermentation product of traditional Chinese medicinechickenEscherichia coli

单文琪、江庆国、张述阳、谭艳平、周铁忠、王宏军

展开 >

锦州医科大学畜牧兽医学院,辽宁锦州 121001

大连三仪动物药品有限公司,辽宁大连 116036

沈阳沈化院测试技术有限公司,辽宁沈阳 110141

四味穿心莲散 益生菌 中草药发酵 大肠杆菌

辽宁省民生科技计划项目辽宁省科学技术计划农业重大专项辽宁省普通本科高等学校校际合作重大科研项目

2021JH2/102000092020JH1/10200003辽教发202028-59

2024

中国饲料
中国饲料工业协会

中国饲料

北大核心
影响因子:0.577
ISSN:1004-3314
年,卷(期):2024.(1)
  • 6